Format

Send to

Choose Destination
  • Filters activated: Field: Title Word. Clear all
AAPS J. 2015 Sep;17(5):1041-54. doi: 10.1208/s12248-015-9780-2. Epub 2015 May 9.

A Review of Clinical Translation of Inorganic Nanoparticles.

Author information

1
Department of Chemical Engineering, Center for Bioengineering, University of California, Santa Barbara, California, 93106, USA.

Abstract

Inorganic nanoparticles are widely used for therapeutic and diagnostic purposes as they offer unique features as compared with their organic and polymeric counterparts. As such, inorganic nanoparticles represent an exciting opportunity to develop drug delivery and imaging systems that are poised to tackle unique challenges which are currently unaddressed in clinical settings. Despite these clear advantages, very few inorganic nanoparticle systems have entered the clinic. Here, we review the current clinical landscape of inorganic nanoparticle systems and their opportunities and challenges, with particular emphasis on gold-, iron-oxide- and silica-based nanoparticle systems. Key examples of inorganic nanoparticles that are currently being investigated in the clinic (e.g., trials which are recruiting or currently active but not completed) are highlighted, along with the preclinical work that these examples have leveraged to transition from the lab to the clinic.

PMID:
25956384
PMCID:
PMC4540735
DOI:
10.1208/s12248-015-9780-2
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center